Share This Page
Suppliers and packagers for generic pharmaceutical drug: SORBITOL
✉ Email this page to a colleague
SORBITOL
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | SORBITOL 3% IN PLASTIC CONTAINER | sorbitol | SOLUTION;IRRIGATION | 017863 | NDA | Baxter Healthcare Corporation | 0338-0295-47 | 3000 mL in 1 BAG (0338-0295-47) | 1980-05-30 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers and packagers for generic pharmaceutical drug: SORBITOL
Sorbitol Pharmaceutical Suppliers: Key Producers, Supply Sources, and Quality-Compliance Coverage
Sorbitol for pharmaceutical use is supplied by a mix of bulk chemical manufacturers and dedicated specialty excipient producers. The dominant supply model is regional bulk production with downstream conversion into pharm-grade formats (typically powder or solution) and packaging under quality systems aligned to excipient expectations (GMP/DMF where applicable, and common pharmacopoeial compliance).
Core reality for sourcing sorbitol (pharma grade): buyers typically dual-source (bulk + repackager/formatter) because sorbitol supply is concentrated in a handful of large producers while pharm-grade dossiers, specifications, and packaging formats vary by supplier and site.
What companies supply pharm-grade sorbitol (USP/EP/FCC) for drug manufacturing?
Major commercial suppliers of sorbitol commonly used as a pharmaceutical excipient include large commodity-to-specialty chemical companies plus excipient-focused ingredient firms. In practice, pharmaceutical customers select suppliers by: (1) pharmacopoeial listing (USP, EP), (2) trace specs (sugars, heavy metals, ash, water), (3) packaging forms (solution, powder, granules), and (4) ability to provide DMFs, certificates, and compliance documentation.
Common supplier profiles in the sorbitol market
- Large chemical manufacturers: offer bulk sorbitol and sorbitol solutions in multiple grades; support regulatory documentation and site traceability.
- Excipients specialists: provide pharm-grade sorbitol with standardized excipient documentation, often including monograph alignment and controlled impurity profiles.
- Regional distributors and repackagers: repackage bulk into pharma packaging sizes; quality is driven by the repackager’s QMS and incoming certificates.
Which suppliers are the biggest global producers of sorbitol for pharmaceutical use?
The global sorbitol base supply is concentrated in multi-plant chemical producers. For pharma-grade sourcing, buyers usually check which sites have documentation aligned to their target market (US or EU) and desired dosage-form specs.
Supplier shortlist used in pharma procurement
Below is a practical set of company names that are repeatedly present across excipient and bulk chemical supply chains for sorbitol:
- Roquette (excipient and specialty chemicals; sorbitol and related polyols in pharma supply channels)
- BASF (polyols and specialty chemical supply; sorbitol presence via portfolio for industrial/specialty grades)
- Cargill (sorbitol and sugar alcohol supply chain presence depending on grade and region)
- Merck KGaA / MilliporeSigma (pharma-relevant distribution through lab/specialty channels; sourcing is grade-dependent)
- Sudzucker (sugar processing group; sorbitol supply and regional availability)
- Matthias/Bio-based polyol producers (regional) (availability varies by country; pharma-grade alignment depends on site certification)
- Carboxymethylcellulose excipient distributors who carry sorbitol (not primary producers, but relevant to pharma sourcing)
(Supplier availability by grade and dossier support depends on the specific site and product form.)
What is the pharma-grade sorbitol spec landscape (USP vs EP) and how do suppliers differ?
Sorbitol in pharma is evaluated against pharmacopoeial monographs, typically with tighter impurity and specification controls than food/industrial grades.
Typical differentiators in supplier offerings
- Pharmacopoeial alignment: USP-grade vs Ph. Eur.-aligned product, including test methods and acceptance limits.
- Color and odor controls: especially for solution forms.
- Reducing sugars and related polyols: impurity profile differences across production routes.
- Water content (for syrups/solutions): impacts stability and viscosity.
- Particle size (for powders): affects dissolution and compressibility where relevant.
How buyers validate
- Certificates of Analysis (CoA) across lots
- Regulatory documentation (DMF/CEP/DMF references where offered)
- Incoming material qualification and stability sampling for final formulations
Which sorbitol forms matter for drug manufacturing, and who supplies each?
Pharmaceutical manufacturing uses sorbitol in multiple forms, and suppliers commonly segment by form.
Form-by-form supply patterns
- Sorbitol solution (sorbitol syrup): commonly used as humectant, cryoprotectant, sweetener, or solvent system component.
- Sorbitol powder / granules: used in tablets, chewables, and as a crystallization control excipient in certain blends.
- Technical-to-pharma grade transitions: some suppliers offer both, but pharma-grade ordering is site- and documentation-dependent.
What excipient regulatory documentation do sorbitol suppliers provide (DMF, CEP, GMP letters)?
Regulatory support is not uniform across sorbitol supply chains. Pharmaceutical buyers typically target documentation aligned to their markets:
- US: DMF (Type II or related filings) is a key differentiator if available for the specific grade/site.
- EU: CEP availability can reduce regulatory friction if the supplier has the dossier scope for the monograph and manufacturing process.
- GMP status: GMP letters, site audits, and controlled manufacturing processes are common procurement requirements.
Procurement decision driver: documentation is often tied to specific manufacturing sites, not just the corporate entity.
Which sourcing routes exist for sorbitol: direct manufacturer vs distributor vs contract packer?
Direct manufacturer
- Best for: consistent supply, site traceability, and full documentation packages.
- Tradeoff: lead times and MOQ constraints.
Distributor / trading company
- Best for: smaller orders, regional availability, faster logistics.
- Tradeoff: relies on distributor chain-of-custody and incoming CoA traceability.
Contract packer / re-packager
- Best for: packaging formats that match clinical or commercial supply chains.
- Tradeoff: repackager QMS becomes part of the compliance stack.
When do sorbitol supply constraints affect pharma buyers, and what mitigation works?
Sorbitol supply moves with feedstock economics and polyol capacity utilization. Pharma buyers mitigate with:
- dual sourcing across different production sites
- safety stock on long lead-time packaging formats
- qualification of alternate grades/forms (within spec)
- pre-approved change control for suppliers that meet packaging and release criteria
How strong are the competitive barriers for sorbitol procurement in pharmaceuticals?
Barriers by dimension
- Documentation barrier: onboarding a new supplier takes regulatory and quality validation.
- Specification barrier: pharma-grade specs are tighter than commodity specs.
- Capacity barrier: global polyol production is concentrated and not easily substituted at short notice.
- Form-factor barrier: powder vs solution vs specific concentration targets require packaging and formulation controls.
What patent landscape affects sorbitol supply for pharmaceuticals?
Sorbitol as an excipient is a commodity-level ingredient with limited “composition-of-matter” patent relevance for general use. Competitive restrictions more often come from:
- process patents (specific production routes) and improvements
- impurities control technologies
- purification and crystallization process know-how at the site level
- regulatory control through DMF/CEP documentation and manufacturing authorization
Patent-driven sourcing constraints are therefore usually indirect compared with the practical bottlenecks of site certification and quality documentation.
Key Takeaways
- Sorbitol pharmaceutical sourcing is dominated by a small set of large chemical producers plus excipient specialists and distributors.
- The primary buyer selection criteria are pharmacopoeial alignment (USP/EP), impurity and trace specs, form factor (powder vs solution), and site-specific documentation (DMF/CEP and GMP).
- Procurement risk is mainly documentation and quality qualification, plus supply continuity driven by site capacity utilization, feedstock economics, and packaging lead times.
- Competitive barriers are practical (QMS validation, specs, change control) more than patent exclusivity.
FAQs
1) Are all sorbitol grades interchangeable for pharmaceutical formulations?
No. Pharma-grade use depends on pharmacopoeial monograph compliance and impurity and specification limits that differ by grade and manufacturing site.
2) Can distributors supply sorbitol for US FDA-regulated drug products?
Yes, if they provide lot traceability, CoAs, and upstream documentation that supports your quality system and regulatory expectations for excipient control.
3) Do sorbitol solutions and sorbitol powder have the same regulatory standing?
They can differ by specification targets such as water content, impurities, and physical form, so compliance is form-specific.
4) What documentation should sorbitol suppliers provide to speed regulatory submissions?
DMF/CEP where available, plus GMP letters, CoA history, and site and specification details tied to the exact product grade and form.
5) How do pharmaceutical buyers qualify a new sorbitol supplier?
Through incoming quality controls, impurity and monograph verification, stability checks in the target formulation, and formal supplier change control documentation.
References (APA)
No sources were provided in the prompt, and none were used.
More… ↓
